The vaccine, developed with the University of Oxford, showed 90% efficacy in one dosing regimen -- when the vaccine was
Britain on Wednesday authorized emergency use of a second COVID-19 vaccine, becoming the first country to greenlight an easy-to-handle shot that its developers hope will become the “vaccine for the